Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash to Debt 4.39
ETRM's Cash to Debt is ranked higher than
75% of the 395 Companies
in the Global Medical Devices industry.

( Industry Median: 2.07 vs. ETRM: 4.39 )
ETRM' s 10-Year Cash to Debt Range
Min: 1.29   Max: No Debt
Current: 4.39

F-Score: 2
Z-Score: -10.12
M-Score: -4.68
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 3/10

vs
industry
vs
history
ROE (%) -186.12
ETRM's ROE (%) is ranked lower than
57% of the 382 Companies
in the Global Medical Devices industry.

( Industry Median: 5.99 vs. ETRM: -186.12 )
ETRM' s 10-Year ROE (%) Range
Min: -1135.7   Max: -77.38
Current: -186.12

-1135.7
-77.38
ROA (%) -104.35
ETRM's ROA (%) is ranked lower than
56% of the 395 Companies
in the Global Medical Devices industry.

( Industry Median: 3.76 vs. ETRM: -104.35 )
ETRM' s 10-Year ROA (%) Range
Min: -962.06   Max: -60.09
Current: -104.35

-962.06
-60.09
ROC (Joel Greenblatt) (%) -4686.90
ETRM's ROC (Joel Greenblatt) (%) is ranked lower than
56% of the 394 Companies
in the Global Medical Devices industry.

( Industry Median: 12.84 vs. ETRM: -4686.90 )
ETRM' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -4167.48   Max: -578.16
Current: -4686.9

-4167.48
-578.16
EBITDA Growth (%) -37.80
ETRM's EBITDA Growth (%) is ranked higher than
53% of the 282 Companies
in the Global Medical Devices industry.

( Industry Median: -2.20 vs. ETRM: -37.80 )
ETRM' s 10-Year EBITDA Growth (%) Range
Min: 0   Max: -37.8
Current: -37.8

EPS Growth (%) -38.90
ETRM's EPS Growth (%) is ranked higher than
52% of the 271 Companies
in the Global Medical Devices industry.

( Industry Median: 1.70 vs. ETRM: -38.90 )
ETRM' s 10-Year EPS Growth (%) Range
Min: -69.1   Max: 41.9
Current: -38.9

-69.1
41.9
» ETRM's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2013

ETRM Guru Trades in Q3 2013

Jim Simons 306,700 sh (New)
Chuck Royce 35,000 sh (-30%)
» More
Q4 2013

ETRM Guru Trades in Q4 2013

Chuck Royce 1,285,000 sh (+3571.43%)
Jim Simons Sold Out
» More
Q1 2014

ETRM Guru Trades in Q1 2014

Chuck Royce 1,285,000 sh (unchged)
» More
Q2 2014

ETRM Guru Trades in Q2 2014

Chuck Royce 1,060,000 sh (-17.51%)
» More
» Details

Insider Trades

Latest Guru Trades with ETRM

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)



No Insider Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 5.09
ETRM's P/B is ranked higher than
60% of the 418 Companies
in the Global Medical Devices industry.

( Industry Median: 3.46 vs. ETRM: 5.09 )
ETRM' s 10-Year P/B Range
Min: 3.02   Max: 10.5
Current: 5.09

3.02
10.5
Current Ratio 2.60
ETRM's Current Ratio is ranked higher than
70% of the 393 Companies
in the Global Medical Devices industry.

( Industry Median: 2.72 vs. ETRM: 2.60 )
ETRM' s 10-Year Current Ratio Range
Min: 2.28   Max: 9.46
Current: 2.6

2.28
9.46
Quick Ratio 2.50
ETRM's Quick Ratio is ranked higher than
77% of the 393 Companies
in the Global Medical Devices industry.

( Industry Median: 2.07 vs. ETRM: 2.50 )
ETRM' s 10-Year Quick Ratio Range
Min: 2.28   Max: 9.46
Current: 2.5

2.28
9.46

Valuation & Return

vs
industry
vs
history
Price/Net Cash 6.22
ETRM's Price/Net Cash is ranked higher than
96% of the 418 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. ETRM: 6.22 )
ETRM' s 10-Year Price/Net Cash Range
Min: 1.48   Max: 84.53
Current: 6.22

1.48
84.53
Price/Net Current Asset Value 6.22
ETRM's Price/Net Current Asset Value is ranked higher than
93% of the 418 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. ETRM: 6.22 )
ETRM' s 10-Year Price/Net Current Asset Value Range
Min: 1.48   Max: 84.53
Current: 6.22

1.48
84.53
Price/Tangible Book 5.09
ETRM's Price/Tangible Book is ranked higher than
71% of the 418 Companies
in the Global Medical Devices industry.

( Industry Median: 5.91 vs. ETRM: 5.09 )
ETRM' s 10-Year Price/Tangible Book Range
Min: 1.42   Max: 44.22
Current: 5.09

1.42
44.22
Forward Rate of Return (Yacktman) -166.62
ETRM's Forward Rate of Return (Yacktman) is ranked lower than
52% of the 318 Companies
in the Global Medical Devices industry.

( Industry Median: 1.19 vs. ETRM: -166.62 )
ETRM' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 0   Max: 0
Current: -166.62

Business Description

Industry: Medical Devices » Medical Devices
Compare: » details
Traded in other countries:BY8N.Germany
EnteroMedics, Inc., a development stage medical device company engaged in design and development of devices that use neuroblocking technology to treat obesity, its associated co-morbidities, and other gastrointestinal disorders.
» More Articles for ETRM

Headlines

Articles On GuruFocus.com
EnteroMedics Inc. Reports Operating Results (10-K) Mar 07 2011 
EnteroMedics Inc. Reports Operating Results (10-Q) Nov 08 2010 
EnteroMedics Inc. Reports Operating Results (10-Q) Aug 06 2010 
EnteroMedics Inc. Reports Operating Results (10-Q) May 07 2010 
EnteroMedics Inc. Reports Operating Results (10-Q) Nov 16 2009 
EnteroMedics Inc. Reports Operating Results (10-Q) Aug 07 2009 
EnteroMedics Inc. Reports Operating Results (10-Q) May 07 2009 
EnteroMedics Reports 2008 Year-End Financial Results Jan 29 2009 

More From Other Websites
Nasdaq stocks posting largest volume increases Sep 19 2014
Journal of the American Medical Association Publishes EnteroMedics' ReCharge Pivotal Trial Results Sep 03 2014
EnteroMedics Announces Three Year Diabetes, Hypertension and Weight Loss Data from the Maestro® RC... Aug 28 2014
ENTEROMEDICS INC Financials Aug 19 2014
ENTEROMEDICS INC Files SEC form 10-Q, Quarterly Report Aug 08 2014
ENTEROMEDICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Aug 07 2014
EnteroMedics Reports Second Quarter 2014 Financial Results Aug 07 2014
EnteroMedics to Participate in Canaccord Genuity 34th Annual Growth Conference Aug 06 2014
EnteroMedics to Host Second Quarter 2014 Financial Results and Business Update Conference Call Jul 29 2014
ENTEROMEDICS INC Files SEC form 8-K, Change in Directors or Principal Officers Jun 25 2014
ENTEROMEDICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jun 20 2014
Why EnteroMedics (ETRM) Stock Is Surging Today Jun 18 2014
US STOCKS-Futures little changed ahead of Fed statement Jun 18 2014
ENTEROMEDICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jun 18 2014
EnteroMedics Announces FDA Advisory Committee Recommendation on VBLOC(R) Vagal Blocking Therapy for... Jun 17 2014
ENTEROMEDICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a... Jun 13 2014
Enteromedics' Prospects Worsen With FDA Panel Documents' Release Jun 13 2014
EnteroMedics Device Faces FDA Panel June 17th With Weak Clinical Data Jun 12 2014
EnteroMedics: A Preview of the Weight-Loss Zapper FDA Panel Jun 12 2014
EnteroMedics (ETRM) in Focus: Stock Falls 6.0% in Session Jun 06 2014

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK